Medidata NEXT London 2026 LIVE

DTRA’s Craig Lipset on Decentralized Trials and Accelerating Rare Disease Research

New technologies have always driven advances in clinical research, and that’s still true today. The Covid pandemic rapidly accelerated the adoption of decentralized trials, powered by emerging health tech, but in less dramatic times, life sciences must find ways to ensure continued innovation. As an industry veteran and co-chair of the Digital Trials & Research Alliance (DTRA), Craig Lipset has a powerful perspective on the potential of emerging technologies, and how to successfully combat inertia and encourage adoption in clinical studies. He joins Medidata CEO Anthony Costello to explore the origins of decentralized trials, the potential of Virtual Twins, and how the Buffalo Initiative is promoting research into understudied rare diseases. Visit our website [https://mdso.io/63cddc] Read our blog [https://mdso.io/ze1] Follow Medidata: LinkedIn [https://mdso.io/s7r], Instagram [https://mdso.io/rng], X [https://mdso.io/8du], YouTube [https://mdso.io/7rm] Follow Anthony: LinkedIn [https://mdso.io/mfp] Follow Craig: LinkedIn [https://mdso.io/wq7]

Medidata NEXT London 2026 LIVE

At its heart, Medidata NEXT is a conversation where leading experts in clinical research come together in open dialogue. Representing the biggest names in healthcare and life sciences from around the world, they explore industry challenges and share their excitement for what the future holds. That made NEXT Innovation Day London the perfect venue for our latest live edition of from Dreamers to Disruptors. Recorded straight from the show floor, Medidata leaders and a broad range of guests break down the power and incredible potential of AI across the clinical trial process, combining diverse perspectives into a united vision for the next era of healthcare technology. Session 1 Speakers: * Edward Ford | Vice President, Client Engagement, Medidata * Anthony Costello | CEO, Medidata * Nitish Mittal | Partner, Everest Group * Krzysztof Wróblewski | Head of Global Clinical Solutions Technologies, Senior Director, AstraZeneca Session 2 Speakers: * Aryana Hosseinkhani | Vice President, Head of Product Marketing, Medidata * Lisa Moneymaker | Chief Strategy Officer, Medidata * Chris Standley | Vice President, Vendor Governance, Worldwide Clinical Trials Session 3 Speakers: * Wayne Walker | GM, Head of Data Experience, Medidata * Robyn Orie | Sr. Director, Data Innovation, Caidya * Cassie Kendrew | Chief Operating Officer, EMS Healthcare * Amardeep Heer | Medidata Site Insights Board Member | Principal Investigator, Lakeside Healthcare Visit our website [https://mdso.io/63cddc] Read our blog [https://mdso.io/ze1] Follow Medidata: LinkedIn [https://mdso.io/s7r], Instagram [https://mdso.io/rng], X [https://mdso.io/8du], YouTube [https://mdso.io/7rm]

Fighting Cancer with External Control Arms: Friends of Cancer Research’s Jeff Allen

External Control Arms are a powerful clinical research tool, harnessing cutting-edge tech to fill gaps in clinical data and accelerate trials when patients’ lives are on the line. They’re particularly valuable for cancer research, where patients can neither afford to wait nor settle for the current standard of care. Friends of Cancer Research President and CEO Jeff Allen sits down with Medidata CEO Anthony Costello and Senior Vice President, Statistics and Regulatory Science Innovation Ruthie Davi to celebrate 30 years of oncology innovation, and explore what’s coming next. They dig deep into Medidata and Friends’ partnership to bring the power of External Control Arms to pancreatic cancer research, and how to build a future where clinical research takes full advantage of these life-saving innovations. Visit our website [https://mdso.io/63cddc] Read our blog [https://mdso.io/ze1] Follow Medidata: LinkedIn [https://mdso.io/s7r], Instagram [https://mdso.io/rng], X [https://mdso.io/8du], YouTube [https://mdso.io/7rm] Follow Anthony: LinkedIn [https://mdso.io/mfp] Follow Jeff: LinkedIn [https://mdso.io/bvx] Follow Ruthie: LinkedIn [https://mdso.io/ryf]

Medidata NEXT New York 2026 LIVE

NEXT New York is our flagship event, bringing together the world’s leading life sciences companies and thinkers to envision a transformative future for healthcare that challenges our preconceptions of what’s possible in clinical trials. This special edition of from Dreamers to Disruptors was recorded live from the show floor at NEXT, capturing the hottest takes and insights from Medidata leaders and special guests. From the end-to-end AI support reshaping studies, to building trust in cutting-edge clinical technologies, our speakers share their fresh perspectives on what matters most to pharma professionals today. Session 1 Speakers: * Edward Ford | Vice President, Client Engagement, Medidata * Anthony Costello | CEO, Medidata * Matteo di Tommaso | Senior Vice President, R&D Business Insights & Technology, Bristol Myers Squibb * Nimita Limaye | Research Vice President, Life Sciences R&D Strategy and Technology, IDC Session 2 Speakers: * Aryana Hosseinkhani | Vice President, Head of Product Marketing, Medidata * Meghan Harrington | Vice President, Clinical Trial Financial Management, Medidata * Paul O'Donohoe | Senior Director, eCOA Product and Science, Medidata * Sharlene Carnegie | Senior Vice President, Product and Engineering, Medidata Session 3 Speakers: * Jeff Ventimiglia | Senior Vice President, Offering and Portfolio Management, Medidata * Bryant Fields | Vice President, Partnerships, Medidata * Robert Lyons | Vice President, Engineering, Medidata * Jia Chen | Head, Product, AI, Medidata Session 4 Speakers: * Lisa Moneymaker | Senior Vice President, Chief Strategy Officer, Medidata * Tom Doyle | Senior Vice President, Chief Technology Officer, Medidata * Claire Biot | Vice President, Life Sciences and Healthcare Industry, Dassault Systèmes * Patrick Johnson | EVP, Corporate Research and Sciences, Dassault Systèmes Visit our website [https://mdso.io/63cddc] Read our blog [https://mdso.io/ze1] Follow Medidata: LinkedIn [https://mdso.io/s7r], Instagram [https://mdso.io/rng], X [https://mdso.io/8du], YouTube [https://mdso.io/7rm]

Investing in the Future of Healthcare: 7wire Ventures’ Lee Shapiro

As a veteran entrepreneur in life sciences, Lee Shapiro has invested in some of the most transformative technologies in modern healthcare history—developing a deep understanding of what makes for truly successful innovation. Medidata CEO Anthony Costello sits down with Lee to discover the secret to his success. Charting his work across a variety of leading life sciences organizations, from Allscripts and Livongo, to Click Therapeutics and Medidata itself, Lee uncovers the qualities that underpin the most accomplished enterprises. Join Lee and Anthony as they paint a powerful picture of our evolving industry and explore the disruptions shaping the future of healthcare. Visit our website [https://mdso.io/63cddc] Read our blog [https://mdso.io/ze1] Follow Medidata: LinkedIn [https://mdso.io/s7r], Instagram [https://mdso.io/rng], X [https://mdso.io/8du], YouTube [https://mdso.io/7rm] Follow Anthony: LinkedIn [https://mdso.io/mfp] Follow Lee: LinkedIn [https://mdso.io/4pa]